Searchable abstracts of presentations at key conferences in endocrinology

ea0014p426 | (1) | ECE2007

Dehydroepiandrosterone and bone mineral density in elderly women

Papierska Lucyna , Rabijewski Michal , Wiktorowicz-Dudek Agnieszka , Zgliczynski Wojciech

Dehydroepiandrosterone (DHEA) and its sulphate (DHEAS) are weak adrenal androgens, which may exert anabolic effect on bone tissue.We have measured serum DHEAS levels and bone mineral density in lumbar spine and femoral neck in 131 healthy, agile, postmenopausal women aged 59–89. There were no diseases which aggravate bone loss and no hormonal replacement therapy in medical history of participants.Women were divided into groups...

ea0014p600 | (1) | ECE2007

Thyrotropinoma response to somatostatin receptor ligand (SRL) – key feature in preoperative treatment

Zgliczynski Wojciech , Zdunowski Piotr , Gietka-Czernel Malgorzata , Zielinski Grzegorz

Background: TSH-secreting tumors appears as extremely rare cause of hyperthyroidism. Major clinical feature is preserved TSH level in subjects with apparent thyrotoxicosis. Misdiagnosis of primary thyroid hyper function led to mistreatment with anti-thyroid agents. This worsens disease course and outcome. Neurosurgery success rate is limited by large tumor size and extrasellular expansion. Somatostatin plays key role in regulation of TSH secretion. Tumors in most cases express...

ea0056gp15 | Adrenal Case reports | ECE2018

Etomidate for the management of severe hypercortisolaemia in different clinical scenarios – a case series

Lebek-Szatanska Agnieszka , Nowak Karolina M , Zgliczynski Wojciech , Papierska Lucyna

Cushing’s syndrome is associated with life-threatening complications, as well as high rates of perioperative mortality and morbidity. Authors present clinical scenarios, in which one should consider the usage of intravenous etomidate as an accurate, safe and effective drug for hypercortisolaemia.Case 1: 23-year-old female with severe Cushing’s syndrome due to metastatic adrenocortical carcinoma was admitted to the Department of Endocrinology. S...

ea0056ep1 | Adrenal and Neuroendocrine Tumours | ECE2018

Is pheochromocytoma a diagnostics chameleon indeed? Series of cases

Juszczyszyn Marta , Papierska Lucyna , Cwikla Jaroslaw , Zgliczynski Wojciech

Presence of clinical symptoms and signs specific for suspected illness is, in general, a condition sine qua non to start diagnostics procedures. However, some diseases may proceed with various and disparate symptoms, which often suggests completely different diagnosis. One of them is pheochromocytoma – rare, usually benign neoplasm derived from chromaffin cells of adrenal medulla. It is very important to diagnose the disease while it is curable by surgery like ma...

ea0073aep325 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Association of glucocorticoid receptor gene polymorphism A3669G (9β) with lower glucose concentration 2 hours after OGTT in patients during chronic glucocorticoid treatment

Nowak Karolina , Sobalska-Kwapis Marta , Zgliczynski Wojciech , Papierska Lucyna

Background2–3% of the general population is chronically treated with glucocorticoids (GCs). Modification of the structure and/or function of the glucocorticoid receptor (GR) due to its polymorphisms may result in increased (GC – S – bclI, N363S) or decreased (GC – I – A3669G, ER22/23EK) sensitivity to GCs. To date, whether such modulation of cell’s response to GCs can be associated with presence or absence of the side effect...

ea0049ep469 | Diabetes (to include epidemiology, pathophysiology) | ECE2017

Evaluation of oral glucose tolerance test as a screening test detecting glucose metabolism impairment in patients chronically treated with glucocorticoids without previous history of diabetes

Nowak Karolina , Romanowska-Prochnicka Katarzyna , Bornikowska Katarzyna , Zgliczynski Wojciech , Papierska Lucyna

Introduction: One of the most common side effects of glucocorticoid treatment is glucose intolerance and diabetes. Although glucocorticoids cause mainly postprandial hyperglycaemia the International Diabetes Federation, American Diabetes Association and The European League Against Rheumatism recommend to screen patients chronically treated with glucocorticoids by regularly determining fasting plasma glucose. Such an approach can lead to false negative results. Since pre-diabet...

ea0041ep9 | Adrenal cortex (to include Cushing's) | ECE2016

The use of [131I] 6β-iodomethyl-norcholesterol scintigraphy in evaluation of adrenal tumors

Papierska Lucyna , Rabijewski Michal , Kaminska Anna , Cwikla Jaroslaw , Otto Maciej , Cichocki Andrzej , Samsel Radoslaw , Zgliczynski Wojciech

Adrenal cortex scintigraphy has been used as early as in the 1970s, however, in recent years, it has been a rarely performed and unappreciated examination. In fact, this examination does not provide a perfect view on morphology of adrenal glands, however it provides an assessment of the examined tumor’s function. The aim of this work is to present our experience with adrenal cortex scintigraphy in assessment of adrenal tumors.We present a series of ...

ea0037ep666 | Pituitary: basic and neuroendocrinology | ECE2015

Dose interval injection extension and costs of lanreotide Autogel 120 mg used in routine acromegaly care in Poland: 2 years data from Lanro study

Orlewska Ewa , Kos-Kudla Beata , Sowinski Jerzy , Sworczak Krzysztof , Zgliczynski Wojciech

Objective: To determine the percentage of patients with acromegaly who received lanreotide Autogel 120 mg (ATG120) in extended duration interval and to evaluate the mean costs of ATG120 administered as part of routine care in Poland.Methods: National, multicentre, non-interventional, observational prospective study with 2-years’ time horizon. The study population consisted of adult acromegaly patients who received at least three injections of ATG120...

ea0035p251 | Clinical case reports Pituitary/Adrenal | ECE2014

Primary hyperthyroidism following successful surgical treatment for secondary hyperthyroidism due to TSH-secreting pituitary adenoma

Czajka-Oraniec Izabella , Baranowska-Bik Agnieszka , Kochman Magdalena , Zielinski Grzegorz , Zgliczynski Wojciech

Introduction: Secondary hyperthyroidism due to thyrotropin-secreting pituitary adenoma (TSHoma) is rare. Coexistence of TSHoma and primary thyroid disease that could lead to hyperthyroidism is even more unusual.Case report: A 28-year-old female with longstanding and worsening symptoms of hyperthyroidism was admitted to the hospital. Free-T4 (32.89 pmol/l) and free-T3 (6.38 pg/ml) were elevated with moderately increased TSH level (5....

ea0035p672 | Growth hormone IGF axis basic | ECE2014

Demographic and clinical characteristics and treatment patterns of polish acromegalic patients switched to lanreotide AUTOGEL 120

Orlewska Ewa , Kos-Kudla Beata , Sowinski Jerzy , Sworczak Krzysztof , Zgliczynski Wojciech

Objective: The aim of the study was to examine characteristics and treatment patterns of Polish acromegalic patients.Methods: A retrospective database analysis was conducted. Adult acromegalic patients treated medically for ≥1 year including at least three injections of lanreotide AUTOGEL 120 were recruited in 36 centres between 29/10/2010 and 31/03/2012. Descriptive analysis was performed to describe demographic and clinical characteristics, treat...